IGF2BP2 and neoplasm: This reduced immune presence is likely due to the role of IMP2 in regulating immune-related pathways and altering the tumor microenvironment to be less favorable for immune cell activity, possibly through the modulation of extracellular matrix components or cytokine profiles.